Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-361
HER2amp
Luminal
ZM-447439
AURK
AURK
10999.15
uM
5.18730
0.35596
0.4787 0.4393 0.7871 0.2250
0.9020
0.7928
MDA-MB-361
HER2amp
Luminal
ZM-447439
AURK
AURK
12379.169
uM
2.84960
1.58770
0.3859 0.4731 4.9984 0.1591
0.9361
0.5957
MDA-MB-415
HR+
Luminal
(Z)-4-Hydroxytamoxifen
ESR1
7897.016
uM
32.84980
48.58170
-0.9480 -1.0000 2.8076 0.2266
0.9871
0.7300
MDA-MB-415
HR+
Luminal
17-AAG
HSP90
HSP90
9664.037
uM
0.09572
0.11439
-0.9995 -0.7190 5.0000 0.8937
0.9660
0.7953
MDA-MB-415
HR+
Luminal
17-AAG
HSP90
HSP90
7897.037
uM
0.01547
0.02922
-0.9359 -0.7663 1.4609 1.1406
0.9681
0.7255
MDA-MB-415
HR+
Luminal
2-deoxyglucose
12959.177
uM
inf
inf
0.3997 0.3997 0.0000 0.1758
0.1401
0.5538
MDA-MB-415
HR+
Luminal
5-DFUR
TYMS
TYMS
12333.143
uM
69.31480
1000.00000
-0.2174 -0.7755 0.3509 0.4155
0.8044
0.6265
MDA-MB-415
HR+
Luminal
5-DFUR
TYMS
TYMS
10938.143
uM
2.97220
999.99980
0.0360 -0.5648 0.1299 0.5525
0.8889
1.0173
MDA-MB-415
HR+
Luminal
5-FU
TYMS
TYMS
7897.035
uM
199.69580
698.60690
-0.7189 -0.8653 0.8021 0.5067
0.9935
0.8378
MDA-MB-415
HR+
Luminal
Afatinib
EGFR/HER2
ErbB
12333.165
uM
0.76831
1.79190
-0.9988 -1.0000 1.2973 0.7164
0.9035
0.6207
MDA-MB-415
HR+
Luminal
AG1024
IGF1R
RTK
7511.066
uM
inf
inf
0.9792 0.9792 0.0000 -0.0212
-0.3797
1.1691
MDA-MB-415
HR+
Luminal
AG1024
IGF1R
RTK
7512.066
uM
inf
inf
0.9738 0.9738 0.0000 -0.0064
-0.0661
0.8629
MDA-MB-415
HR+
Luminal
AG1024
IGF1R
RTK
7510.066
uM
inf
inf
0.7164 0.7164 0.0000 0.1448
0.1074
0.9189
MDA-MB-415
HR+
Luminal
AG1478
EGFR
ErbB
7897.016
uM
inf
inf
0.7698 0.7698 0.0000 0.0413
0.3296
0.7300
MDA-MB-415
HR+
Luminal
AS-252424
PI3K
PI3K
12333.165
uM
inf
0.00107
0.6376 0.6596 4.9998 0.2729
0.7587
0.6207
MDA-MB-415
HR+
Luminal
AS-252424
PI3K
PI3K
10938.153
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.4228
MDA-MB-415
HR+
Luminal
Baicalein
Lipoxygenase
Metabolism
7511.073
uM
inf
52.84510
0.6306 0.6292 4.8844 0.0134
0.9407
1.0909
MDA-MB-415
HR+
Luminal
Baicalein
Lipoxygenase
Metabolism
10938.072
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.5611
MDA-MB-415
HR+
Luminal
Bortezomib
Proteasome
Proteasome
7512.074
uM
0.11726
0.18064
-0.9205 -0.8344 2.2716 1.0037
0.9881
0.9022
MDA-MB-415
HR+
Luminal
Bortezomib
Proteasome
Proteasome
7512.074
uM
0.11726
0.18064
-0.9205 -0.8344 2.2716 1.0037
0.9881
0.9022
MDA-MB-415
HR+
Luminal
Bortezomib
Proteasome
Proteasome
14845.203
uM
0.01985
0.04922
-0.9548 -0.8923 1.1277 1.0483
0.9930
0.7023
MDA-MB-415
HR+
Luminal
Bortezomib
Proteasome
Proteasome
14845.203
uM
0.01985
0.04922
-0.9548 -0.8923 1.1277 1.0483
0.9930
0.7023
MDA-MB-415
HR+
Luminal
Bortezomib
Proteasome
Proteasome
7510.074
uM
0.16354
0.20064
-0.9653 -0.8900 5.0000 0.9948
0.9955
0.7920
MDA-MB-415
HR+
Luminal
Bortezomib
Proteasome
Proteasome
7510.074
uM
0.16354
0.20064
-0.9653 -0.8900 5.0000 0.9948
0.9955
0.7920
MDA-MB-415
HR+
Luminal
Bortezomib
Proteasome
Proteasome
7511.074
uM
0.09189
0.13938
-0.8458 -0.7677 2.2329 0.9765
0.9962
1.2617